New York City-based Memorial Sloan Kettering, one of the leading cancer care systems in the country, has reported a $1.5 million operating income for the first half of 2023.
The move into positive territory follows an operating loss of $138.1 million reported in the same period last year.
While operating revenues rose to $3.5 billion for the period, expenses increased 8.2 percent with salaries and benefits rising 4.2 percent to total $1.8 billion.
Overall income totaled $132.4 million versus a net loss of $869.6 million in 2022. Days' cash on hand totaled 328 as of June 30.